Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Allena Pharmaceuticals, Inc. (ALNAQ) had Return on Tangible Equity of -225.47% for the most recently reported fiscal quarter, ending 2022-06-30.
| Income Statement Financials | |
-- |
|
$-8.44M |
|
-- |
|
-- |
|
$6.92M |
|
$-6.92M |
|
$-1.51M |
|
$-8.44M |
|
$-8.06M |
|
$-8.44M |
|
$-8.44M |
|
$-8.44M |
|
$-8.06M |
|
$-6.92M |
|
$-6.81M |
|
100.62M |
|
100.62M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$16.49M |
|
$0.93M |
|
$1.32M |
|
$17.81M |
|
$10.43M |
|
-- |
|
$3.65M |
|
$14.07M |
|
$3.74M |
|
$3.74M |
|
$3.74M |
|
107.72M |
|
| Cash Flow Statement Financials | |
$-24.59M |
|
$0.00M |
|
$1.20M |
|
$29.99M |
|
$6.59M |
|
$-23.40M |
|
$1.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.58 |
|
-- |
|
-- |
|
-- |
|
1.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-225.47% |
|
|
Return on Tangible Equity |
-225.47% |
-47.36% |
|
-225.47% |
|
$0.03 |
|
$-0.24 |
|
$-0.24 |
|